Table 4. Significantly enriched GO terms and KEGG pathways in the low-risk group.
GO | ID | Description | NSE | p.adjust |
BP | GO:0045088 | Regulation of innate immune response | 2.65 | <0.001 |
BP | GO:0031349 | Positive regulation of defense response | 2.63 | <0.001 |
BP | GO:0002218 | Activation of innate immune response | 2.61 | <0.001 |
BP | GO:0032088 | Negative regulation of NF-κB transcription factor activity | 2.57 | <0.001 |
BP | GO:0009615 | Response to virus | 2.57 | <0.001 |
KEGG | hsa05416 | Viral myocarditis | 2.56 | <0.001 |
KEGG | hsa04630 | JAK-STAT signaling pathway | 2.46 | <0.001 |
KEGG | hsa04650 | Natural killer cell-mediated cytotoxicity | 2.46 | <0.001 |
KEGG | hsa04062 | Chemokine signaling pathway | 2.43 | <0.001 |
KEGG | hsa04612 | Antigen processing and presentation | 2.43 | <0.001 |
BP, biological process; CC, cellular component; GO, gene ontology; MF, molecular function.